|
ALG10B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.70580002847964E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.647500003088E-08 |
| Normal-vs-Stage2 |
5.81109999999718E-05 |
| Normal-vs-Stage3 |
1.25489999502904E-08 |
| Normal-vs-Stage4 |
7.85129999902878E-08 |
| Stage1-vs-Stage2 |
8.458600E-01 |
| Stage1-vs-Stage3 |
1.465980E-01 |
| Stage1-vs-Stage4 |
1.106770E-01 |
| Stage2-vs-Stage3 |
4.316800E-01 |
| Stage2-vs-Stage4 |
2.684200E-01 |
| Stage3-vs-Stage4 |
6.680000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.40849995503112E-09 |
| Normal-vs-AfricanAmerican |
2.122500E-03 |
| Normal-vs-Asian |
4.12190000020907E-07 |
| Caucasian-vs-AfricanAmerican |
8.649600E-01 |
| Caucasian-vs-Asian |
3.551200E-01 |
| AfricanAmerican-vs-Asian |
4.516200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.07909999824685E-08 |
| Normal-vs-Female |
2.18639994997716E-09 |
| Male-vs-Female |
4.568600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.76179999980641E-07 |
| Normal-vs-Age(41-60Yrs) |
4.66119998154824E-09 |
| Normal-vs-Age(61-80Yrs) |
9.26450000049428E-08 |
| Normal-vs-Age(81-100Yrs) |
2.425800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.854020E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.984000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.086000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.211200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.541600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.782600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.001600E-02 |
| Classical-VS-Follicular |
3.583600E-01 |
| Classical-VS-Other |
6.639200E-01 |
| Classical-VS-Normal |
4.48170000000303E-08 |
| Tall-VS-Follicular |
1.280840E-01 |
| Tall-VS-Other |
4.831800E-01 |
| Tall-VS-Normal |
4.01519999471134E-08 |
| Follicular-VS-Other |
9.076000E-01 |
| Follicular-VS-Normal |
9.68020000047254E-07 |
| Other-VS-Normal |
2.764200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.35269999645971E-08 |
| Normal-vs-N1 |
3.61820000005508E-06 |
| N0-vs-N1 |
8.670800E-01 |
|
|
